Priority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting – Analysis of a Cluster Randomized Controlled Trial (WestGem-Study)

Rose, Olaf; Mennemann, Hugo; John, Carina; Lautenschläger, M; Mertens-Keller, Damaris; Richling, Katharina; Waltering, Isabel; Hamacher, Stefanie; Felsch, Moritz; Herich, Lena; Czarnecki, Kathrin; Schaffert, Corinna; Jaehde, Ulrich; Köberlein-Neu, Juliane

doi:10.1371/journal.pone.0156304

Cited by 34 publications

(29 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, in our study, the type and number of implemented pharmaceutical recommendations affected the observed change in the quality of medication therapy. The process evaluation yielded a mean implementation rate of pharmaceutical suggestions of 54.9%; the rate increased the longer physician and pharmacist had been cooperating (33). The identified number of drugrelated problems corresponds to comparable studies (34,35).…”

Section: Results In the Context Of The Published Literaturementioning

confidence: 79%

“…Larger followup studies should adapt the intervention to a wider and optimized community setting. The authors' own secondary analyses demonstrated, for example, that not all patients benefitted equally from participating in medication management (33). In view of the resource implications associated with the interdisciplinary management of patients, criteria for how to select suitable patients might be conceived.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Interprofessional Medication Management in Patients With Multiple Morbidities

Köberlein-Neu

Mennemann²,

Hamacher

et al. 2016

Deutsches Ärzteblatt International

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Results In the Context Of The Published Literaturementioning

confidence: 79%

Section: Discussionmentioning

confidence: 99%

Interprofessional Medication Management in Patients With Multiple Morbidities

Köberlein-Neu

Mennemann²,

Hamacher

et al. 2016

Deutsches Ärzteblatt International

Self Cite

View full text Add to dashboard Cite

show abstract

“…Unfortunately, there is inconsistency within Canada, and internationally, regarding what this service typically entails. 41 The goals of medication review programs in some Canadian provinces are to confirm an individual patient’s medication list and to help them to better understand their medications. Medication review programs in other provinces go further and require pharmacists to assess the indication, efficacy, safety, and convenience of the patient’s medications to identify drug therapy problems and make care plans to optimize health outcomes, in collaboration with the other care providers (e.g., Comprehensive Care Plans in Alberta).…”

Section: Primary Care Services Offered By Community Pharmaciesmentioning

confidence: 99%

Community pharmacists’ evolving role in Canadian primary health care: a vision of harmonization in a patchwork system

Raiche

Pammett

Dattani

et al. 2020

Pharm Pract (Granada)

View full text Add to dashboard Cite

Canada’s universal public health care system provides physician, diagnostic, and hospital services at no cost to all Canadians, accounting for approximately 70% of the 264 billion CAD spent in health expenditure yearly. Pharmacy-related services, including prescription drugs, however, are not universally publicly insured. Although this system underpins the Canadian identity, primary health care reform has long been desired by Canadians wanting better access to high quality, effective, patient-centred, and safe primary care services. A nationally coordinated approach to remodel the primary health care system was incited at the turn of the 21st century yet, twenty years later, evidence of widespread meaningful improvement remains underwhelming. As a provincial/territorial responsibility, the organization and provision of primary care remains discordant across the country. Canadian pharmacists are, now more than ever, poised and primed to provide care integrated with the rest of the primary health care system. However, the self-regulation of the profession of pharmacy is also a provincial/territorial mandate, making progress toward integration of pharmacists into the primary care system incongruent across jurisdictions. Among 11,000 pharmacies, Canada’s 28,000 community pharmacists possess varying authority to prescribe, administer, and monitor drug therapies as an extension to their traditional dispensing role. Expanded professional services offered at most community pharmacies include medication reviews, minor/common ailment management, pharmacist prescribing for existing prescriptions, smoking cessation counselling, and administration of injectable drugs and vaccinations. Barriers to widely offering these services include uncertainties around remuneration, perceived skepticism from other providers about pharmacists’ skills, and slow digital modernization including limited access by pharmacists to patient health records held by other professionals. Each province/territory enables pharmacists to offer these services under specific legislation, practice standards, and remuneration models unique to their jurisdiction. There is also a small, but growing, number of pharmacists across the country working within interdisciplinary primary care teams. To achieve meaningful, consistent, and seamless integration into the interdisciplinary model of Canadian primary health care reform, pharmacy advocacy groups across the country must coordinate and collaborate on a harmonized vision for innovation in primary care integration, and move toward implementing that vision with ongoing collaboration on primary health care initiatives, strategic plans, and policies. Canadians deserve to receive timely, equitable, and safe interdisciplinary care within a coordinated primary health care system, including from their pharmacy team.

show abstract

“…The MAI‐change is strongly related to pre‐interventional appropriateness: the higher the MAI at baseline the higher the mean reduction. A MAI‐baseline‐score ≥24 was identified as a possible cut‐off value to initiate a medication review . In clinical practice the MAI could be used to pre‐assess whose medication needs to be assessed and which patients potentially benefit from a medication review.…”

mentioning

confidence: 99%